Artelo Biosciences (ARTL)
(Real Time Quote from BATS)
$1.08 USD
+0.02 (1.89%)
Updated Sep 23, 2024 12:26 PM ET
4-Sell of 5 4
F Value D Growth B Momentum F VGM
Cash flow Statements
Fiscal Year End for Artelo Biosciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -9.29 | -10.08 | -2.55 | -7.44 | -4.65 |
Depreciation/Amortization & Depletion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change from Assets/Liabilities | 0.66 | -0.42 | 0.05 | -0.24 | -0.04 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 0.42 | 2.50 | 0.58 | 1.54 | 0.35 |
Net Cash From Operating Activities | -8.21 | -8.01 | -1.93 | -6.14 | -4.35 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 3.51 | 2.96 | -8.88 | -3.44 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 3.51 | 2.96 | -8.88 | -3.44 | 0.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.57 | 0.00 | 18.26 | 14.12 | 1.98 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
Net Cash from Financing Activities | 0.57 | 0.00 | 18.26 | 14.11 | 1.98 |
Effect of Exchange Rate Changes | 0.06 | -0.22 | -0.04 | -0.05 | 0.08 |
Net Change In Cash & Equivalents | -4.07 | -5.27 | 7.42 | 4.49 | -2.28 |
Cash at Beginning of Period | 6.89 | 12.16 | 6.63 | 2.14 | 4.42 |
Cash at End of Period | 2.82 | 6.89 | 14.05 | 6.63 | 2.14 |
Diluted Net EPS | -3.14 | -3.56 | -6.00 | -6.00 | -18.89 |
Fiscal Year End for Artelo Biosciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -4.92 | -2.48 | -9.29 | -6.22 | -3.77 |
Depreciation/Amortization & Depletion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change from Assets/Liabilities | -0.33 | -0.57 | 0.66 | 0.25 | -0.33 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 0.24 | 0.12 | 0.42 | 0.36 | 0.29 |
Net Cash From Operating Activities | -5.01 | -2.94 | -8.21 | -5.61 | -3.81 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 3.02 | 1.27 | 3.51 | 0.77 | 2.60 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 3.02 | 1.27 | 3.51 | 0.77 | 2.60 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.06 | 0.06 | 0.57 | 0.54 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.06 | 0.06 | 0.57 | 0.54 | 0.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.06 | 0.06 | 0.04 |
Net Change In Cash & Equivalents | -1.93 | -1.62 | -4.07 | -4.25 | -1.17 |
Cash at Beginning of Period | 2.82 | 2.82 | 6.89 | 6.89 | 6.89 |
Cash at End of Period | 0.88 | 1.20 | 2.82 | 2.64 | 5.72 |
Diluted Net EPS | -0.75 | -0.78 | -0.99 | -0.83 | -0.56 |